NO20040206L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number: NO20040206L
Authority: NO; Norway
Prior art keywords: alkyl; halo; alkoxy; halogen; hydrogen
Prior art date: 2001-07-17

Application number

NO20040206A

Other languages

English (en)

Inventor

Yves St-Denis

Romano Di Fabio

Fabrizio Micheli

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-17

Filing date

2004-01-16

Publication date

2004-03-16

2004-01-16 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-03-16 Publication of NO20040206L publication Critical patent/NO20040206L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Endocrinology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

NO20040206A 2001-07-17 2004-01-16 Kjemiske forbindelser NO20040206L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0117396.2A GB0117396D0 (en)	2001-07-17	2001-07-17	Chemical compounds
PCT/EP2002/007865 WO2003008412A2 (en)	2001-07-17	2002-07-15	Hetero-bicyclic crf antagonists

Publications (1)

Publication Number	Publication Date
NO20040206L true NO20040206L (no)	2004-03-16

Family

ID=9918655

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040206A NO20040206L (no)	2001-07-17	2004-01-16	Kjemiske forbindelser

Country Status (27)

Country	Link
US (2)	US7253284B2 (no)
EP (2)	EP1695974B1 (no)
JP (1)	JP4459616B2 (no)
KR (2)	KR20090110386A (no)
CN (1)	CN100447141C (no)
AT (2)	ATE338042T1 (no)
AU (1)	AU2002328899B2 (no)
BR (1)	BR0211171A (no)
CA (1)	CA2451530A1 (no)
CO (1)	CO5550437A2 (no)
CY (1)	CY1105780T1 (no)
DE (2)	DE60235729D1 (no)
DK (1)	DK1425280T3 (no)
ES (2)	ES2342417T3 (no)
GB (2)	GB0117396D0 (no)
HK (1)	HK1066535A1 (no)
HU (1)	HUP0400465A2 (no)
IL (1)	IL159254A0 (no)
MX (1)	MXPA04000494A (no)
NO (1)	NO20040206L (no)
NZ (1)	NZ530043A (no)
PL (1)	PL368053A1 (no)
PT (1)	PT1425280E (no)
RU (1)	RU2310655C2 (no)
SI (1)	SI1425280T1 (no)
WO (1)	WO2003008412A2 (no)
ZA (1)	ZA200309708B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE397609T1 (de) *	2001-06-12	2008-06-15	Glaxo Group Ltd	Corticotropinfreisetzungsfaktor antagonisten
ATE359782T1 (de) *	2003-01-16	2007-05-15	Sb Pharmco Inc	Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
GB0308208D0 (en) *	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
NZ547990A (en)	2003-12-22	2010-04-30	Smithkline Beecham Cork Ltd	CRF receptor antagonists and methods relating thereto
US7652035B2 (en) *	2004-10-19	2010-01-26	Neurocrine Bioscience, Inc.	CRF receptor antagonists and methods relating thereto
GB0519957D0 (en)	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
US8088779B2 (en)	2005-09-30	2012-01-03	Smithkline Beecham (Cork) Limited	Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
US8513420B2 (en)	2007-03-19	2013-08-20	Monika Mazik	Amino-naphthyridine derivatives
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru)	2007-06-04	2014-11-28	Синерджи Фармасьютикалз Инк.	Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
WO2009008552A1 (en) *	2007-07-11	2009-01-15	Taisho Pharmaceutical Co., Ltd.	8-aryl-4-alkylpyrrolo[2,3,4-de]quinolin-5(4h)-one and 8-aryl-4-alkyl-4,5-dihydropyrrolo[2,3,4-de]quinolin-5-ol derivatives
CA2930674A1 (en)	2008-06-04	2009-12-10	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja)	2008-07-16	2011-11-17	シナジーファーマシューティカルズインコーポレイテッド	胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
BR112015016395A2 (pt)	2013-01-18	2017-07-11	Hoffmann La Roche	pirazóis 3-substituídos e uso como inibidores de dlk
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
JP2016514670A (ja)	2013-03-15	2016-05-23	シナジーファーマシューティカルズインコーポレイテッド	他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5169857A (en) *	1988-01-20	1992-12-08	Bayer Aktiengesellschaft	7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
NO177005C (no) *	1988-01-20	1995-07-05	Bayer Ag	Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
GB2248618B (en)	1988-06-17	1993-01-06	Wyeth John & Brother Ltd	Process for preparing pyridine derivatives
CA2022408A1 (en)	1989-08-31	1991-03-01	Michael P. Bodman	Process for preparing pyridine carboxylic acid derivatives
DK0495982T3 (da)	1989-10-11	1996-07-01	Teijin Ltd	Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
DE4022414A1 (de)	1990-07-13	1992-01-16	Bayer Ag	Substituierte pyrrolo-pyridine
AU665184B2 (en)	1991-01-23	1995-12-21	Gensia, Inc.	Adenosine kinase inhibitors
US5246944A (en) *	1991-08-13	1993-09-21	Merck & Co., Inc.	Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
GB9125842D0 (en)	1991-12-04	1992-02-05	Ici Plc	Heterocyclic derivatives
EP0633886B1 (en)	1992-04-03	2000-10-18	PHARMACIA & UPJOHN COMPANY	Pharmaceutically active bicyclic-heterocyclic amines
US5502187A (en) *	1992-04-03	1996-03-26	The Upjohn Company	Pharmaceutically active bicyclic-heterocyclic amines
JPH0710876A (ja)	1993-06-24	1995-01-13	Teijin Ltd	４位に環状アミノ基を有するピロロ［２，３―ｄ］ピリミジン
JP3398152B2 (ja)	1993-10-12	2003-04-21	ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー	１ｎ−アルキル−ｎ−アリールピリミジンアミンおよびその誘導体
AU692484B2 (en) *	1993-10-12	1998-06-11	Du Pont Pharmaceuticals Company	1N-alkyl-N-arylpyrimidinamines and derivatives thereof
TW530047B (en)	1994-06-08	2003-05-01	Pfizer	Corticotropin releasing factor antagonists
ATE182332T1 (de)	1994-06-16	1999-08-15	Pfizer	Pyrazolo und pyrrolopyridine
EP0729758A3 (en)	1995-03-02	1997-10-29	Pfizer	Pyrazolopyrimidines and pyrrolopyrimidines to treat neuronal disorders and other diseases
US6403599B1 (en)	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
US5955613A (en) *	1995-10-13	1999-09-21	Neurogen Corporation	Certain pyrrolopyridine derivatives; novel CRF1 specific ligands
AU738304B2 (en) *	1995-10-13	2001-09-13	Neurogen Corporation	Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands
DK0920429T3 (da)	1996-08-06	2003-05-12	Pfizer	Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
TW477787B (en) *	1996-08-27	2002-03-01	Pfizer	Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
CZ68199A3 (cs) *	1996-08-28	1999-11-17	Pfizer Inc.	6,5-Heterobicyklické deriváty, farmaceutická kompozice na jejich bázi a způsob léčení chorob
WO1998035967A2 (en)	1997-02-18	1998-08-20	Neurocrine Biosciences, Inc.	Biazacyclic crf antagonists
WO1999007703A1 (en)	1997-08-05	1999-02-18	Pfizer Products Inc.	4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
JP2002510687A (ja) *	1998-04-02	2002-04-09	ニューロゲンコーポレイション	アミノアルキル置換ピロロ［２，３−ｂ］ピリジンおよびピロロ［２，３−ｄ］ピリミジン誘導体：ｃｒｆ１レセプタのモジュレータ
JPH11335376A (ja)	1998-05-25	1999-12-07	Taisho Pharmaceut Co Ltd	アリールテトラヒドロピリジン誘導体
JP2000086663A (ja)	1998-09-09	2000-03-28	Taisho Pharmaceut Co Ltd	アリールテトラヒドロピリジン誘導体
JP2002540206A (ja)	1999-03-11	2002-11-26	ニューロゲンコーポレイション	アリールの縮合した２，４−二置換ピリジン：ｎｋ３受容体リガンド
JP2002540203A (ja)	1999-03-29	2002-11-26	ニューロゲンコーポレイション	Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体
FR2791675B1 (fr)	1999-03-30	2001-05-04	Synthelabo	Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
EP1040831A3 (en)	1999-04-02	2003-05-02	Pfizer Products Inc.	Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
US6284766B1 (en)	1999-04-30	2001-09-04	Neurogen Corporation	9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands
CA2379640C (en)	1999-09-30	2006-11-28	Neurogen Corporation	Certain alkylene diamine-substituted heterocycles
US6525067B1 (en)	1999-11-23	2003-02-25	Pfizer Inc	Substituted heterocyclic derivatives
AU779995B2 (en)	2000-01-18	2005-02-24	Pfizer Products Inc.	Corticotropin releasing factor antagonists
AR028782A1 (es)	2000-07-05	2003-05-21	Taisho Pharmaceutical Co Ltd	Derivados heterociclicos tetrahidropiridino o piperidino
WO2002019975A1 (fr)	2000-09-05	2002-03-14	Taisho Pharmaceutical Co., Ltd.	Stimulants de la croissance des cheveux
GB0100622D0 (en)	2001-01-10	2001-02-21	Vernalis Res Ltd	Chemical compounds V111
US20040110785A1 (en)	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
DE60225127T2 (de) *	2001-04-30	2009-02-19	Glaxo Group Ltd., Greenford	Kondensierte pyrimidine als antagonisten des corticotropin releasing factor (crf)
ATE397609T1 (de) *	2001-06-12	2008-06-15	Glaxo Group Ltd	Corticotropinfreisetzungsfaktor antagonisten
AU2002336462A1 (en)	2001-09-06	2003-03-24	Millennium Pharmaceuticals, Inc.	Piperazine and homopiperazine compounds
SE0201980D0 (sv)	2002-06-24	2002-06-24	Astrazeneca Ab	Novel compounds
ATE359782T1 (de)	2003-01-16	2007-05-15	Sb Pharmco Inc	Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
EP1592690A1 (en) *	2003-02-14	2005-11-09	Wyeth	Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds

2001
- 2001-07-17 GB GBGB0117396.2A patent/GB0117396D0/en not_active Ceased
2002
- 2002-07-11 GB GB0216041A patent/GB2378702A/en not_active Withdrawn
- 2002-07-15 IL IL15925402A patent/IL159254A0/xx unknown
- 2002-07-15 WO PCT/EP2002/007865 patent/WO2003008412A2/en active Application Filing
- 2002-07-15 DE DE60235729T patent/DE60235729D1/de not_active Expired - Lifetime
- 2002-07-15 US US10/483,792 patent/US7253284B2/en not_active Expired - Fee Related
- 2002-07-15 CN CNB02813866XA patent/CN100447141C/zh not_active Expired - Fee Related
- 2002-07-15 BR BR0211171-3A patent/BR0211171A/pt not_active IP Right Cessation
- 2002-07-15 NZ NZ530043A patent/NZ530043A/xx unknown
- 2002-07-15 AT AT02764696T patent/ATE338042T1/de not_active IP Right Cessation
- 2002-07-15 HU HU0400465A patent/HUP0400465A2/hu unknown
- 2002-07-15 AU AU2002328899A patent/AU2002328899B2/en not_active Ceased
- 2002-07-15 EP EP06076176A patent/EP1695974B1/en not_active Expired - Lifetime
- 2002-07-15 PT PT02764696T patent/PT1425280E/pt unknown
- 2002-07-15 KR KR1020097020632A patent/KR20090110386A/ko not_active Application Discontinuation
- 2002-07-15 KR KR1020047000696A patent/KR100961287B1/ko not_active IP Right Cessation
- 2002-07-15 AT AT06076176T patent/ATE461197T1/de not_active IP Right Cessation
- 2002-07-15 EP EP02764696A patent/EP1425280B1/en not_active Expired - Lifetime
- 2002-07-15 SI SI200230419T patent/SI1425280T1/sl unknown
- 2002-07-15 MX MXPA04000494A patent/MXPA04000494A/es active IP Right Grant
- 2002-07-15 RU RU2004104349/04A patent/RU2310655C2/ru not_active IP Right Cessation
- 2002-07-15 JP JP2003513971A patent/JP4459616B2/ja not_active Expired - Fee Related
- 2002-07-15 ES ES06076176T patent/ES2342417T3/es not_active Expired - Lifetime
- 2002-07-15 DE DE60214401T patent/DE60214401T2/de not_active Expired - Lifetime
- 2002-07-15 DK DK02764696T patent/DK1425280T3/da active
- 2002-07-15 CA CA002451530A patent/CA2451530A1/en not_active Abandoned
- 2002-07-15 ES ES02764696T patent/ES2271327T3/es not_active Expired - Lifetime
- 2002-07-15 PL PL02368053A patent/PL368053A1/xx unknown
2003
- 2003-12-15 ZA ZA200309708A patent/ZA200309708B/xx unknown
2004
- 2004-01-16 CO CO04002410A patent/CO5550437A2/es not_active Application Discontinuation
- 2004-01-16 NO NO20040206A patent/NO20040206L/no not_active Application Discontinuation
- 2004-11-30 HK HK04109443A patent/HK1066535A1/xx not_active IP Right Cessation
2006
- 2006-11-14 CY CY20061101650T patent/CY1105780T1/el unknown
2007
- 2007-05-16 US US11/749,433 patent/US20070219232A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GB0216041D0 (en)	2002-08-21
DE60235729D1 (de)	2010-04-29
DE60214401D1 (de)	2006-10-12
ZA200309708B (en)	2005-01-21
RU2004104349A (ru)	2005-03-27
WO2003008412A3 (en)	2003-05-01
JP2005514328A (ja)	2005-05-19
GB0117396D0 (en)	2001-09-05
SI1425280T1 (sl)	2006-12-31
MXPA04000494A (es)	2004-05-04
ATE461197T1 (de)	2010-04-15
EP1695974B1 (en)	2010-03-17
US20070219232A1 (en)	2007-09-20
EP1695974A1 (en)	2006-08-30
ATE338042T1 (de)	2006-09-15
DE60214401T2 (de)	2007-02-22
HK1066535A1 (en)	2005-03-24
WO2003008412A2 (en)	2003-01-30
KR20090110386A (ko)	2009-10-21
CY1105780T1 (el)	2011-02-02
PL368053A1 (en)	2005-03-21
PT1425280E (pt)	2006-12-29
EP1425280B1 (en)	2006-08-30
ES2271327T3 (es)	2007-04-16
GB2378702A (en)	2003-02-19
EP1425280A2 (en)	2004-06-09
JP4459616B2 (ja)	2010-04-28
CN1525972A (zh)	2004-09-01
HUP0400465A2 (hu)	2005-01-28
KR20040023651A (ko)	2004-03-18
RU2310655C2 (ru)	2007-11-20
BR0211171A (pt)	2004-08-10
CN100447141C (zh)	2008-12-31
CO5550437A2 (es)	2005-08-31
DK1425280T3 (da)	2007-01-02
KR100961287B1 (ko)	2010-06-04
CA2451530A1 (en)	2003-01-30
IL159254A0 (en)	2004-06-01
US20040171607A1 (en)	2004-09-02
AU2002328899B2 (en)	2006-12-21
NZ530043A (en)	2006-03-31
ES2342417T3 (es)	2010-07-06
US7253284B2 (en)	2007-08-07

Publication	Publication Date	Title
NO20040206L (no)	2004-03-16	Kjemiske forbindelser
NO20055421L (no)	2005-12-20	Kinolinderivater som fosfodiestrase-inhibitorer
NO20061170L (no)	2006-05-15	Piperazinderivater for behandling av HIV-infeksjoner
NO20070258L (no)	2007-01-15	Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer
TW200508232A (en)	2005-03-01	Bicyclic derivatives, their preparation, pharmaceutical compositions containing them and their use in therapy
NO20035583D0 (no)	2003-12-15	Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner
CY1107747T1 (el)	2013-04-18	Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20082496L (no)	2008-07-24	Pyrazinderivater
MXPA05012247A (es)	2006-02-10	Derivados de bencimidazol nuevos.
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
MXPA05007494A (es)	2005-09-21	Nuevos compuestos.
DE602004005960D1 (de)	2007-05-31	Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
ATE401080T1 (de)	2008-08-15	(3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
DE60226971D1 (de)	2008-07-17	Corticotropinfreisetzungsfaktor antagonisten
NO20040203L (no)	2004-03-16	Kjemiske forbindelser
TH101406B (th)	2010-05-26	สารประกอบตัวใหม่
DK1065206T3 (da)	2002-10-28	Tetrazolylalkylindol-forbindelser som anti-inflammatoriske og analgetiske midler

Legal Events

Date	Code	Title	Description
2010-08-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application